Z
Zvi Vered
Researcher at Tel Aviv University
Publications - 147
Citations - 5849
Zvi Vered is an academic researcher from Tel Aviv University. The author has contributed to research in topics: Heart failure & Myocardial infarction. The author has an hindex of 33, co-authored 146 publications receiving 5548 citations. Previous affiliations of Zvi Vered include Idaho Central Credit Union & Sheba Medical Center.
Papers
More filters
Journal ArticleDOI
Two-dimensional strain-a novel software for real-time quantitative echocardiographic assessment of myocardial function.
Marina Leitman,P. Lysyansky,Stanislav Sidenko,Vladimir Shir,Eli Peleg,Michal Binenbaum,Edo Kaluski,Ricardo Krakover,Zvi Vered +8 more
TL;DR: In this paper, the authors assess the feasibility of 2D strain, a software for real-time quantitative echocardiographic assessment of myocardial function, which is based on the estimation that a discrete set of tissue velocities are present per each of many small elements on the ultrasound image.
Journal ArticleDOI
Myocardial viability as a determinant of the ejection fraction response to carvedilol in patients with heart failure (CHRISTMAS trial): randomised controlled trial
John G.F. Cleland,Dudley J. Pennell,Simon Ray,Andrew J.S. Coats,Peter W. Macfarlane,Gordon D Murray,J. Dalle Mule,Zvi Vered,Avijit Lahiri +8 more
TL;DR: This double-blind, randomised trial to compare placebo and carvedilol for 6 months in individuals with stable, chronic heart failure due to ischaemic left-ventricular systolic dysfunction found that medical treatment might be an important adjunct or alternative to revascularisation for patients with hibernating myocardium.
Journal ArticleDOI
Posttraumatic stress, nonadherence, and adverse outcome in survivors of a myocardial infarction.
TL;DR: PTSD symptoms predicted poor disease control in this cohort of MI survivors and the data suggest that screening MI survivors for symptoms of PTSD may be beneficial if this high-risk population is to be targeted for interventions.
Journal ArticleDOI
High-dose intravenous isosorbide-dinitrate is safer and better than Bi-PAP ventilation combined with conventional treatment for severe pulmonary edema
Ahuva Sharon,Isaac Shpirer,Edo Kaluski,Yaron Moshkovitz,Olga Milovanov,Roman Polak,Alex Blatt,Avi Simovitz,Ori Shaham,Zvi Faigenberg,Michael Metzger,David Stav,Robert Yogev,Ahuva Golik,Rikardo Krakover,Zvi Vered,Gad Cotter +16 more
TL;DR: High dose ISDN is safer and better than BiPAP ventilation combined with conventional therapy in patients with severe pulmonary edema, and the study was prematurely terminated by the safety committee.
Journal ArticleDOI
Thiamine deficiency in patients with congestive heart failure receiving long-term furosemide therapy: a pilot study.
Hanna Seligmann,Hanna Seligmann,Hillel Halkin,Hillel Halkin,Shmuel Rauchfleisch,Shmuel Rauchfleisch,Natan Kaufmann,Natan Kaufmann,Rachel Tal,Rachel Tal,Michael Motro,Michael Motro,Zvi Vered,Zvi Vered,David Ezra,David Ezra +15 more
TL;DR: Preliminary findings suggest that long-term furosemide therapy may be associated with clinically significant thiamine deficiency due to urinary loss and contribute to impaired cardiac performance in patients with CHF.